Long-term Safety and Efficacy of a Once-Daily Regimen of Emtricitabine, Didanosine, and Efavirenz in HIV-Infected, Therapy-Naive Children and Adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021
Ross E. McKinney(Environmental Protection Agency), Mobeen H. Rathore, Chengcheng Hu(University of Arizona), Stephen A. Spector(University of California San Diego), Melissa Scites(University of Florida Health Science Center), Jack Rodman(Boston University), Martin Blum(University of Hohenheim), Linda Draper(Frontier Science & Technology Research Foundation, Inc.), Coleen K. Cunningham(Duke Medical Center), Elaine J. Abrams(ICAP Global Health), Alberto Ortíz(Universidad Pontificia de Salamanca), Joyce Kraimer(Social and Scientific Systems (United States)), Gregory E. Chittick(Chimerix (United States)), Leslie Serchuck, Ruth Dickover(University of California, Davis), Adriana Weinberg(University of Colorado Anschutz Medical Campus), Paul Tran(National Institute of Allergy and Infectious Diseases), Michael D. Hughes(Virginia Tech), Mary E. Smith(National Institutes of Health), Paula Britto(Cancer Research And Biostatistics), Patricia M. Flynn(St. Jude Children's Research Hospital), Laurie Reynolds(Bristol-Myers Squibb (Germany)), Ram Yogev(Northwestern University)
Cited by 47
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580